Two-Pronged Immunotherapy Strategy Cracks Glioblastoma’s Defenses in Preclinical Study
Wistar Institute scientists report that combining the kidney cancer drug axitinib with a 4-1BB agonist overcame myeloid cell suppression and ...
Wistar Institute scientists report that combining the kidney cancer drug axitinib with a 4-1BB agonist overcame myeloid cell suppression and ...
A new review describes how NMDA glutamate receptors on myeloid cells drive calcium-dependent reprogramming toward immunosuppressive states, and how blocking ...
New research in mice shows that age-related loss of Wnt signaling in intervertebral disc cells suppresses chemokine production and blunts ...
A new review argues that patient-derived glioblastoma organoids could finally provide a realistic platform for testing immunotherapies, including oncolytic herpes ...
A combined single-cell and genetic analysis identifies the stress-response gene HSPA1B as a cell-type-specific molecular bridge between COPD and atherosclerosis.
New research shows that blocking the TREM2 receptor reprograms HER2-targeted CAR macrophages from suppressive to inflammatory, tumor-engulfing cells in breast ...
New research reveals that radiotherapy induces PD-1 expression on tumor-associated monocytes through an adenosine-driven signaling pathway, creating an immunosuppressive cell ...
A new review argues that the immune checkpoint VISTA acts as a myeloid-centered axis in tumors, offering a route past ...
A new mouse study finds that deleting RGS2 in myeloid cells does not affect angiotensin II-induced hypertension or organ damage, ...
Researchers have built an open-source single-cell framework that maps injury, resolution and antigen-presentation programs in tumor myeloid cells across cancers.
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine